XYNOMIC PHARMACEUTICALS HOLDINGS, INC.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2019)
- -$25.1M
- Total Assets (FY2019)
- $937.5K
- Total Equity (FY2019)
- -$22.6M
- Cash Flows from Operating Activities (FY2019)
- -$10.7M
Source: XYNOMIC PHARMACEUTICALS HOLDINGS, INC. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
